F Brivio

458 total citations
21 papers, 359 citations indexed

About

F Brivio is a scholar working on Immunology, Oncology and Endocrine and Autonomic Systems. According to data from OpenAlex, F Brivio has authored 21 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Oncology and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in F Brivio's work include Circadian rhythm and melatonin (6 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (4 papers). F Brivio is often cited by papers focused on Circadian rhythm and melatonin (6 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (4 papers). F Brivio collaborates with scholars based in Italy, Switzerland and United States. F Brivio's co-authors include Paolo Lissoni, Luca Fumagalli, Gabriele Tancini, Sandro Barni, E. Tisi, Franco Rovelli, A Ardizzoia, Massimiliano Grassi, Sofia Meregalli and P. Lissoni and has published in prestigious journals such as Cancer, British Journal of Cancer and European Urology.

In The Last Decade

F Brivio

21 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Brivio Italy 11 136 101 94 60 55 21 359
Kiyoshi Okamura Japan 11 53 0.4× 93 0.9× 75 0.8× 51 0.8× 55 1.0× 35 426
M Namiki Japan 11 87 0.6× 34 0.3× 46 0.5× 103 1.7× 54 1.0× 32 459
Norihiko Murakami Japan 8 38 0.3× 35 0.3× 103 1.1× 37 0.6× 43 0.8× 17 374
Partha Sinha United States 9 70 0.5× 66 0.7× 19 0.2× 43 0.7× 120 2.2× 13 338
Igor L. Leskov United States 9 34 0.3× 25 0.2× 66 0.7× 57 0.9× 188 3.4× 10 404
Kristen Solocinski United States 9 214 1.6× 143 1.4× 163 1.7× 124 2.1× 67 1.2× 14 493
Ralf C. Zimmermann United States 10 46 0.3× 27 0.3× 54 0.6× 27 0.5× 142 2.6× 18 494
Juliana Barrios United States 10 34 0.3× 41 0.4× 62 0.7× 87 1.4× 108 2.0× 13 362
Élisabeth Wieduwild France 7 23 0.2× 78 0.8× 166 1.8× 37 0.6× 60 1.1× 9 358
James L. Shellhaas United States 4 29 0.2× 20 0.2× 155 1.6× 50 0.8× 49 0.9× 8 374

Countries citing papers authored by F Brivio

Since Specialization
Citations

This map shows the geographic impact of F Brivio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Brivio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Brivio more than expected).

Fields of papers citing papers by F Brivio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Brivio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Brivio. The network helps show where F Brivio may publish in the future.

Co-authorship network of co-authors of F Brivio

This figure shows the co-authorship network connecting the top 25 collaborators of F Brivio. A scholar is included among the top collaborators of F Brivio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Brivio. F Brivio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brivio, F, et al.. (2000). Abrogation of the Negative Influence of Opioids on IL–2 Immunotherapy of Renal Cell Cancer by Melatonin. European Urology. 38(1). 115–118. 20 indexed citations
2.
Lissoni, P., et al.. (2000). Changes in Circulating Dendritic Cells and IL-12 in Relation to the Angiogenic Factor VEGF during IL-2 Immunotherapy of Metastatic Renal Cell Cancer. The International Journal of Biological Markers. 15(2). 161–164. 12 indexed citations
3.
4.
Lissoni, Paolo, et al.. (1998). In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients. British Journal of Cancer. 77(11). 1957–1960. 12 indexed citations
5.
Lissoni, Paolo, et al.. (1998). [Pharmacokinetics of melatonin].. PubMed. 89(7-8). 381–2. 1 indexed citations
6.
Lissoni, Paolo, Franco Rovelli, Marco Casati, et al.. (1997). Interleukin-12 in early or advanced cancer patients. European Journal of Cancer. 33(10). 1703–1705. 9 indexed citations
7.
8.
Lissoni, Paolo, et al.. (1997). Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancer.. PubMed. 9(2). 63–6. 11 indexed citations
9.
Lissoni, Paolo, F Brivio, Franco Rovelli, et al.. (1997). Clinical significance of erythrosedimentation rate in cancer in relation to cytokine production: correlation with high IL-6 and low IL-2 blood concentrations.. PubMed. 10(2-3). 60–2. 2 indexed citations
10.
Lissoni, Paolo, L Vigorè, R Rescaldani, et al.. (1996). Neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin in AIDS patients with CD4 cell number below 200/mm3: a biological phase-II study.. PubMed. 9(4). 155–8. 9 indexed citations
11.
Brivio, F, et al.. (1996). Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma. Journal of Pineal Research. 21(4). 239–242. 43 indexed citations
12.
Lissoni, P., E. Tisi, F Brivio, et al.. (1996). Relation between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumors.. PubMed. 9(4). 146–9. 15 indexed citations
13.
Brivio, F, et al.. (1995). Pre-operative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma.. PubMed. 87(2). 135–8. 10 indexed citations
14.
Lissoni, Paolo, Antonio Ardizzoia, Sofia Meregalli, et al.. (1994). A CLINICAL-STUDY OF IMMUNOTHERAPY VERSUS ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA. Oncology Reports. 1(6). 1277–80. 3 indexed citations
15.
Lissoni, Paolo, F Brivio, Luca Fumagalli, et al.. (1994). A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors.. PubMed. 8(1). 32–5. 5 indexed citations
16.
Brivio, F, E. Tisi, Franco Rovelli, et al.. (1993). In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2. Cancer. 71(6). 2076–2081. 21 indexed citations
17.
Brivio, F, Paolo Lissoni, R. Redaelli, et al.. (1993). Influence of blood transfusions on surgery-induced immune changes in colorectal carcinoma.. PubMed. 48(7). 331–5. 3 indexed citations
18.
Ardizzoia, A, Paolo Lissoni, F Brivio, et al.. (1993). Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.. PubMed. 6(3). 103–7. 71 indexed citations
19.
Lissoni, Paolo, F Brivio, Antonio Ardizzoia, et al.. (1991). Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2. British Journal of Cancer. 64(5). 956–958. 8 indexed citations
20.
Lissoni, Paolo, Maria Grazia Cattaneo, Franco Rovelli, et al.. (1990). Lack of Changes in Soluble Interleukin-2 Receptor Serum Levels during Chemotherapy-induced Lymphocyte Damage. The International Journal of Biological Markers. 5(1). 43–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyoshi Okamura Breakdown of academic impact, for papers by M Namiki Breakdown of academic impact, for papers by Norihiko Murakami Breakdown of academic impact, for papers by Partha Sinha Breakdown of academic impact, for papers by Igor L. Leskov Breakdown of academic impact, for papers by Kristen Solocinski Breakdown of academic impact, for papers by Ralf C. Zimmermann Breakdown of academic impact, for papers by Juliana Barrios Breakdown of academic impact, for papers by Élisabeth Wieduwild Breakdown of academic impact, for papers by James L. Shellhaas
Rankless by CCL
2026